A citation-based method for searching scientific literature

Kathryn J Schlich-Bakker, Carla C Wárlám-Rodenhuis, Jeanne van Echtelt, Jan van den Bout, Margreet G E M Ausems, Herman F J ten Kroode. Eur J Cancer 2006
Times Cited: 36







List of co-cited articles
252 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.
Kathryn J Schlich-Bakker, Margreet G E M Ausems, Maria Schipper, Herman F J Ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout. Breast Cancer Res Treat 2008
31
48

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
190
38


Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
120
33

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
30

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch. Cancer Epidemiol Biomarkers Prev 2005
66
30

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
25

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout, Margreet G E M Ausems. Genet Med 2007
54
25

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.
Bettina Meiser, Kathy Tucker, Michael Friedlander, Kristine Barlow-Stewart, Elizabeth Lobb, Christobel Saunders, Gillian Mitchell. Breast Cancer Res 2008
40
22

A literature review of the psychological impact of genetic testing on breast cancer patients.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Margreet G E M Ausems. Patient Educ Couns 2006
62
19

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.
Carla C Wárlám-Rodenhuis, Veronica C M Koot, Rob B van der Luijt, Hans F A Vasen, Margreet G E M Ausems. Eur J Cancer 2005
14
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
19


Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
Arwen H Pieterse, Margreet G E M Ausems, Alexandra M Van Dulmen, Frits A Beemer, Jozien M Bensing. Am J Med Genet A 2005
61
16

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Kenneth P Tercyak, Beth N Peshkin, Barbara M Brogan, Tiffani DeMarco, Marie F Pennanen, Shawna C Willey, Colette M Magnant, Sarah Rogers, Claudine Isaacs, Marc D Schwartz. J Clin Oncol 2007
57
16

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Lisa J Herrinton, William E Barlow, Onchee Yu, Ann M Geiger, Joann G Elmore, Mary B Barton, Emily L Harris, Sharon Rolnick, Roy Pardee, Gail Husson,[...]. J Clin Oncol 2005
196
16

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
S K McDonnell, D J Schaid, J L Myers, C S Grant, J H Donohue, J E Woods, M H Frost, J L Johnson, D L Sitta, J M Slezak,[...]. J Clin Oncol 2001
190
16


Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
16

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009
190
16

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
193
13

Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
D G R Evans, F Lalloo, P Hopwood, A Maurice, A Baildam, A Brain, L Barr, A Howell. Eur J Surg Oncol 2005
35
14


Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Alan J Stolier, George M Fuhrman, Lynnette Mauterer, John S Bolton, Duane W Superneau. Breast J 2004
27
18

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
13

The role of BRCA mutation testing in determining breast cancer therapy.
Alison H Trainer, Craig R Lewis, Kathy Tucker, Bettina Meiser, Michael Friedlander, Robyn L Ward. Nat Rev Clin Oncol 2010
67
13

Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Bettina Meiser, Margaret Gleeson, Kaaren Watts, Michelle Peate, Elvira Zilliacus, Kristine Barlow-Stewart, Christobel Saunders, Gillian Mitchell, Judy Kirk. Oncol Nurs Forum 2012
22
22

Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
Marijke R Wevers, Margreet G E M Ausems, Senno Verhoef, Eveline M A Bleiker, Daniela E E Hahn, Frans B L Hogervorst, Rob B van der Luijt, Heiddis B Valdimarsdottir, Richard van Hillegersberg, Emiel J T H Rutgers,[...]. BMC Cancer 2011
19
26



Screening for adjustment disorders and major depressive disorders in cancer in-patients.
D Razavi, N Delvaux, C Farvacques, E Robaye. Br J Psychiatry 1990
375
11

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
11

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Valérie Bonadona, Pierre Saltel, Françoise Desseigne, Hervé Mignotte, Jean-Christophe Saurin, Qing Wang, Olga Sinilnikova, Sophie Giraud, Gilles Freyer, Henri Plauchu,[...]. Cancer Epidemiol Biomarkers Prev 2002
66
11

Prevention and management of hereditary breast cancer.
Steven A Narod, Kenneth Offit. J Clin Oncol 2005
107
11

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
Mariëlle S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Am J Med Genet A 2004
48
11

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
L N Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, P Devilee,[...]. J Med Genet 1999
60
11

What do women really want to know? Motives for attending familial breast cancer clinics.
C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten. J Med Genet 2002
54
11

Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.
Dejana Braithwaite, Jon Emery, Fiona Walter, A Toby Prevost, Stephen Sutton. J Natl Cancer Inst 2004
133
11

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
Pål Møller, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø. Eur J Cancer 2007
82
11


Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004
420
11

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
178
11


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
11

Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Genet Test 2004
36
11

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.
Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler,[...]. Lancet 2010
11

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
E Van Riel, C C Wárlám-Rodenhuis, S Verhoef, E J T H Rutgers, M G E M Ausems. Eur J Cancer Care (Engl) 2010
38
11

Expanding DNA diagnostic panel testing: is more better?
Eric W Klee, Nicole L Hoppman-Chaney, Matthew J Ferber. Expert Rev Mol Diagn 2011
36
11

Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.
Susan T Vadaparampil, Gwendolyn Pickard Quinn, Jennifer Brzosowicz, Cheryl A Miree. J Psychosoc Oncol 2008
15
26

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
78
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.